![]() |
Volumn 23, Issue 3, 2009, Pages 219-223
|
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) meeting summary. Advances toward measuring diabetic retinopathy and neuropathy: from the bench to the clinic and back again (April 4-5, 2007, Baltimore, Maryland)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
3 NITROTYROSINE;
ADVANCED GLYCATION END PRODUCT RECEPTOR;
BIOLOGICAL MARKER;
CASPASE;
GROWTH FACTOR RECEPTOR;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;
PROTEIN P75;
TUBULIN;
ANATOMICAL VARIATION;
ARTICLE;
CLINICAL ASSESSMENT;
CLINICAL FEATURE;
CONFOCAL MICROSCOPY;
CONTROLLED STUDY;
DIABETIC NEUROPATHY;
DIABETIC PATIENT;
DIABETIC RETINOPATHY;
DIABETOGENESIS;
DISEASE ASSOCIATION;
DISEASE COURSE;
DISEASE MODEL;
ELECTRORETINOGRAM;
EYE EXAMINATION;
GOLD STANDARD;
HISTOPATHOLOGY;
HUMAN;
MOUSE;
NATIONAL HEALTH ORGANIZATION;
NEUROFILAMENT;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
OPTICAL COHERENCE TOMOGRAPHY;
PATHOPHYSIOLOGY;
PHENOTYPE;
PRIORITY JOURNAL;
SPINAL GANGLION;
ANIMALS;
DIABETIC NEUROPATHIES;
DIABETIC RETINOPATHY;
HUMANS;
MARYLAND;
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES (U.S.);
TIME FACTORS;
UNITED STATES;
|
EID: 65249138235
PISSN: 10568727
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jdiacomp.2007.11.001 Document Type: Article |
Times cited : (6)
|
References (0)
|